Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Current Medicinal Chemistry|November 17, 2004
Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyrLuca Costantino, Daniela BarloccoFuture Medicinal Chemistry|April 1, 2015
New perspectives on the development of antiobesity drugsLuca Costantino, Daniela BarloccoJournal of Medicinal Chemistry|March 24, 2016
Ten Years of Medicinal Chemistry (2005-2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public-Private PartnershipsLuca Costantino, Daniela BarloccoMolecules (Basel, Switzerland)|July 8, 2017
Special Issue: Frontiers in Antimicrobial Drug Discovery and DesignDaniela Barlocco, Fiorella MeneghettiFuture Medicinal Chemistry|March 24, 2011
Ghrelin receptor modulators and their therapeutic potentialLuca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|February 7, 2006
Privileged structures as leads in medicinal chemistryLuca Costantino, Daniela BarloccoPharmaceuticals (Basel, Switzerland)|March 28, 2024
Novel Antibacterial Agents 2022Fiorella Meneghetti, Daniela BarloccoExpert Opinion on Therapeutic Patents|July 23, 2014
Ghrelin receptor modulators: a patent review (2011 - 2014)Luca Costantino, Daniela BarloccoCurrent Medicinal Chemistry|May 14, 2008
STAT 3 as a target for cancer drug discoveryLuca Costantino, Daniela BarloccoFuture Medicinal Chemistry|April 30, 2011
Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapyDaniela Masciocchi, Arianna Gelain, Stefania Villa, et al.Pageof 4